0001567619-22-016296.txt : 20220815
0001567619-22-016296.hdr.sgml : 20220815
20220815183912
ACCESSION NUMBER: 0001567619-22-016296
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220811
FILED AS OF DATE: 20220815
DATE AS OF CHANGE: 20220815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grais Linda
CENTRAL INDEX KEY: 0001413306
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37719
FILM NUMBER: 221167862
MAIL ADDRESS:
STREET 1: 86 ALEJANDRA AVE
CITY: ATHERTON
STATE: CA
ZIP: 94027
FORMER NAME:
FORMER CONFORMED NAME: Grais Linda S
DATE OF NAME CHANGE: 20070924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001626971
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464670809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: (650) 900-4520
MAIL ADDRESS:
STREET 1: 863 MITTEN ROAD
STREET 2: SUITE 102
CITY: BURLINGAME
STATE: CA
ZIP: 94010
4
1
doc1.xml
FORM 4
X0306
4
2022-08-11
0
0001626971
Corvus Pharmaceuticals, Inc.
CRVS
0001413306
Grais Linda
C/O CORVUS PHARMACEUTICALS, INC.
863 MITTEN ROAD, SUITE 102
BURLINGAME
CA
94010
1
0
0
0
Stock Option (Right to Buy)
0.965
2022-08-11
4
A
0
15000
0.00
A
2032-08-11
Common Stock
15000
15000
D
The underlying shares subject to the option vest and become exercisable as to one-twelfth (1/12th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Leiv Lea, as Attorney-in-Fact for Linda S. Grais
2022-08-15